Company Search:
Advanced Search
Sponsored Links
Sprint Bioscience AB Company Snapshot
Sprint Bioscience AB operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Sprint Bioscience AB with three other companies in this sector in Sweden: Curando Nordic AB (2018 sales of 15.64 million Swedish Kronor [US$1.65 million] ), Xbrane Biopharma Ab (20.49 million Swedish Kronor [US$2.16 million] of which 380% was Biosimilars), and Active Biotech AB (20.05 million Swedish Kronor [US$2.11 million] of which 80% was Rental revenues).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Sprint Bioscience AB
  Stock Performance Chart for Sprint Bioscience AB
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 11.70
(Figures in Swedish Kronor)
1 Week -4.5%   13 Weeks -8.9%  
4 Weeks -26.4%   52 Weeks -46.6%  
Sprint Bioscience AB Key Data:
  Ticker: SPRINT Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 17,936,000
(Year Ending Jan 2019).
Employees: 27
  Currency: Swedish Kronor Market Cap: 136,042,452
  Fiscal Yr Ends: December Shares Outstanding: 11,627,560
  Share Type: Aktie Closely Held Shares: N/A
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.